LUNGevity Foundation and Johns Hopkins School of Public Health are working together to field a study aimed at understanding what lung cancer patients want from their treatments. This first-of-its-kind, innovative study will help us incorporate your preferences and values into lung cancer drug development, regulatory policies, and education materials.
This survey is for people living with lung cancer or their caregivers. You must be 18 years or older and live in the United States to participate.
The survey is now closed; results will be published when they are available.